Kura Oncology (KURA) Return on Invested Capital (2025 - 2026)
Kura Oncology's (KURA) quarterly Return on Invested Capital came in at 0.33% in Q1 2026, down 33.71% on a QoQ basis from 0.24% in Q4 2025.
Kura Oncology (KURA) Return on Invested Capital (2025 - 2026) Analysis & Trends
Kura Oncology (KURA) has 2 years of Return on Invested Capital data on file, last reported at 0.33% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.97 Bn | 466.18 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.05 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.42 Bn | 959.66 Mn | - |
| 10 | Kura Oncology | 923.32 Mn | 923.32 Mn | 18.00 Mn | -0.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.33% |
| Dec 31, 2025 | -0.24% |